Focus V has shown limited PFS benefit, a high incidence of AEs, and no demonstrated improvement in overall survival.

The body changes capecitabine into a common chemotherapy drug called fluorouracil. It stops cells from making and repairing DNA ... You should contact your advice line urgently if you think you have ...

Explore how cutting-edge agents like alpelisib, capivasertib, MEK and ERK inhibitors, and JAK inhibitors are reshaping the ...

Satri-cel, a CLDN18.2-targeted CAR T-cell therapy, nearly doubles progression-free survival in patients with previously ...

Amgen has detailed a positive phase 3 readout for its T-cell engager Imdelltra in previously treated small cell lung cancer ...

In developing this automated cell therapy processing platform, Limula’s founders aim to create a disruptive production ...

A Falmouth teen, Jayden Wilsey, is the first to receive gene therapy to treat sickle cell at Boston Children's Hospital.

Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...